APA (7th ed.) Citation

Yuko Tsukahara, Beatriz Ferran, Erika T. Minetti, Brian S. H. Chong, Adam C. Gower, Markus M. Bachschmid, & Reiko Matsui. (2022). Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. MDPI AG.

Chicago Style (17th ed.) Citation

Yuko Tsukahara, Beatriz Ferran, Erika T. Minetti, Brian S. H. Chong, Adam C. Gower, Markus M. Bachschmid, and Reiko Matsui. Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. MDPI AG, 2022.

MLA (9th ed.) Citation

Yuko Tsukahara, et al. Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. MDPI AG, 2022.